– 53.7% mean splicing correction observed following a single 15 mg/kg dose of PGN-EDODM1, with all patients showing an improvement in splicing – – PGN-EDODM1 was generally well-tolerated at 15 mg/kg, ...

PepGen Inc. (NASDAQ: PEPG) stock is skyrocketing on Thursday, with a session volume of 53.04 million compared to the average volume of 943.2 thousand as per data from Benzinga Pro. PepGen on Wednesday ...

Investing.com -- PepGen Inc. (NASDAQ:PEPG) stock surged 145% after the clinical-stage biotechnology company announced unprecedented splicing correction results in patients with myotonic dystrophy type ...

– 53.7% mean splicing correction observed following a single 15 mg/kg dose of PGN-EDODM1, with all patients showing an improvement in splicing – – PGN-EDODM1 was generally well-tolerated at 15 mg/kg, ...

(RTTNews) - Several biotech stocks hit new highs during regular trading on Wednesday, with some extending their gains in after-hours trading. While positive trial results in myotonic dystrophy type 1 ...